Study affirms most basic complexities related with COVID-19 Kumar Jeetendra | December 8, 2020 A large study of patients in america who contracted coronavirus disease 2019 (COVID-19) confirms many complications of the disease, according to new research in CMAJ (Canadian Medical Association Journal). Understanding the full range of associated conditions can aid in prognosis, guide treatment decisions and better inform patients as to their actual risks for the variety …
Pfizer plans layered pricing in India, free shots in Africa Kumar Jeetendra | December 9, 2020 Pfizer Inc has decided to price its COVID-19 vaccine candidate, BNT162b2 COVID-19, on the basis of the GDP of the country. The Chief Executive Officer of the American pharmaceutical company, Albert Bourla, has said the company will have tiered pricing to its middle-income nations, including India. The COVID-19 vaccine developed by Pfizer and BioNTech was …
Oxford-AstraZeneca vaccines is protected and compelling, peer-assessed study affirms Kumar Jeetendra | December 9, 2020 COVID-19 vaccines from Pfizer/BioNTech and Moderna have reported efficiency levels of more than 90 percent in late stage trials. Oxford University and AstraZeneca COVID-19 vaccine is safe and highly effective in preventing coronavirus disease, confirms data published in The Lancet, a medical journal, on December 8. Detailed results from the AstraZeneca/Oxford trials have been eagerly …
Conceivable new anti-microbial created for drug-resistant pulmonary microorganism Kumar Jeetendra | December 9, 2020 Scientists from Johns Hopkins University and Medicine have developed a potential new antibiotic for a pathogen that is notoriously resistant to drugs and often lethal for people with cystic fibrosis and other lung disorders. The pathogen, called Mycobacterium abscessus, is related to some better-known bacterium that causes tuberculosis and leprosy but has recently emerged as …
Researchers give knowledge on how lung microorganisms secure against attacking microbes Kumar Jeetendra | December 9, 2020 New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal. The study in mice shows that a strain of lung bacteria called Lactobacillus provides a barrier against Streptococcus pneumoniae (S. pneumoniae) colonisation in animals previously infected with influenza A virus when applied therapeutically following …
Digital Rate & Total Indicator Kumar Jeetendra | December 9, 2020 The Pulsite Solo from Titan Enterprises is a low cost, digital rate and total display indicator that is adaptable to suit almost any flow and rate measurement application across the manufacturing sector. Requiring no external power, the compact Pulsite Solo has multiple mounting possibilities and can be configured to any flow element. Programming on the …
Estonia based Digital-health consultation provider “VIVEO” launches in India Kumar Jeetendra | December 10, 2020 Mumbai, Thursday, 10 December 2020: Estonia-based tech innovator VIVEO Health, a large integrated tele-health provider today announced the seamless expansion of its operations in India. The expansion falls in line with an increased demand due to the COVID-19 pandemic for remote consulting platforms specially designed for medical professionals with an urge to provide a safe …
UK cautions individuals with serious allergies to maintain a strategic distance from Pfizer vaccine after two unfavorable responses Kumar Jeetendra | December 10, 2020 Britain’s medication regulator said anyone with a history of anaphylaxis to a medicine or food should not get the Pfizer-BioNTech COVID-19 vaccine, giving more advice on an earlier allergy warning about the shot. Starting with the elderly and frontline workers, Britain began mass vaccinating its population on Tuesday, part of a worldwide drive that poses …
Indian researchers recognize new potential drug medicines for COVID-19 Kumar Jeetendra | December 10, 2020 Indian scientists have identified drugs and possible cocktails that could target vital proteins of the novel coronavirus, and might possibly help treat COVID-19. Using a virtual screening of this DrugBank database, the study published in the journal Scientific Reports, identified a variety of as yet unexplored ways to attack SARS-CoV-2, even as it mutates. …
New consortium aims to comprehend principles underlying the formation of coronaviruses Kumar Jeetendra | December 10, 2020 “This consortium will aim to comprehend the physical principles underlying the formation of coronaviruses,” said Roya Zandi, a professor of physics and astronomy at UC Riverside and the principal investigator of this four-year project that received funding of over $1.75 million. “We will also explore the effect of some drugs on the assembly process.” Zandi …
Colon lining discharges hydrogen peroxide to shield the body from gut microorganisms Kumar Jeetendra | December 10, 2020 Scientists at UC Davis Health have discovered that an enzyme in the colon lining releases hydrogen peroxide (H2O2) – a known disinfecting chemical – to protect the body from gut microbes. Their study, published Dec. 9 in the journal Cell Host and Microbe, sheds light on the way microorganisms are spatially organized in the colon. …
APIS Assay Technologies Ltd. and Moffitt Cancer Center sign Master Collaboration Agreement on TROLL Biomarker assessment Kumar Jeetendra | December 10, 2020 Manchester, England – 10th November 2020 – APIS Assay Technologies Ltd. has entered into a Research & Development agreement with the Laboratory of Elsa Flores, Ph.D., and Marco Napoli, Ph.D. characterising the suitability of TROLL-2 and TROLL-3 as predictive biomarkers of cancer progression with the goal to assess the role of TROLLs as markers of …
